Allergan rejects Valeant and Ackman's raised takeover offer-Reuters

Botox maker Allergan Inc on Tuesday rejected a sweetened $53 billion takeover offer from Valeant Pharmaceuticals International and activist investor William Ackman, reiterating that it undervalues the company and is too risky for shareholders, Reuters reported.

DealsNorth AmericaUSBriefs